Yu-Ning Wong, MD MSCE

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
Corporal Michael J. Crescenz Veterans Affairs Medical Center
3800 Woodland Avenue
Rehabilitation Medicine Service
Philadelphia, PA 19104
Office: 2158235800x6822/5220
Education:
BA
University of Virginia, 1995.
MD
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 1999.
MS (Clinical Epidemiology)
University of Pennsylvania, 2006.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Cancer treatment outcomes
Cancer treatment decision making
Genitourinary Malignancies

Selected Publications

Hungria V, Martínez-Baños DM, Peñafiel CM, Miguel CE, Jorge Vela-Ojeda5, Remaggi G, Duarte FB, Cao C, Cugliari MS,Santos T, Machnicki G, Fernandez, M, Grings M, Ammann EM, Lin JH, Chen, Y-W, Wong, Y-N, Barreyro P. : Multiple Myeloma Treatment Patterns and Clinical Outcomes in the Latin America Hemato-Oncology (HOLA) Observational Study, 2008-2016. Br J Haematol. Aug 7 2019 Notes: Epub ahead of print.

Li P, Jahnke J, Pettit AR, Wong YN, Doshi JA: Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma. JAMA Netw Open 2(6): e195806, Jun 5 2019.

Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Lee DI, Guzzo TJ, Vapiwala N, Wong YN, Newman DK, Van Arsdalen K, Malkowicz SB, Schwartz JS, Wein AJ.: Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial. J Clin Oncol. 37(12): 964-973, Apr 2019.

Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G.: Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 16(2): e315-e322, Apr 2018.

Shore ND, Saltzstein DR, Sieber PR, Mehlhaff B, Gervasi L, Phillips J, Wong Y, Pei H, McGowan T: Real-world study of enzalutamide and abiraterone acetate (with prednisone) tolerability (REAAcT): Results. Genitourinary Cancers Symposium, San Francisco, CA Feb 2018 Notes: Poster Presentation.

Sartor O, Vogelzang NJ, Sweeney C, Fernandez DC, Almeida F, Iagaru A, Brown A Jr, Smith MR, Agrawal M, Dicker AP, Garcia JA, Lutzky J, Wong YN, Petrenciuc O, Gratt J, Shore ND, Morris MJ; U.S. Expanded Access Program Investigators.: Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. Oncologist. 23(2): 193-202, Feb 2018.

Tetzlaff ED, Hylton HM, DeMora L, Ruth K, Wong YN.: National Study of Burnout and Career Satisfaction Among Physician Assistants in Oncology: Implications for Team-Based Care. J Oncol Pract. 14(1): e11-e22, Jan 2018.

Vachani A, Wong YN, Israelite J, Mitra N, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld PW, Epstein AJ.: Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer. Med Care. 55(12): e131-e6, Dec 2017.

Meeker CR, Wong YN, Egleston BL, Hall MJ, Plimack ER, Martin LP, von Mehren M, Lewis BR, Geynisman DM.: Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis. J Natl Compr Canc Netw. 15(10): 1224-1233, Oct 2017.

Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M.: Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clin Genitourin Cancer. 15(3): e337-e343, Jun 2017.

back to top
Last updated: 11/07/2020
The Trustees of the University of Pennsylvania